Literature DB >> 18043974

Origin of cancer stem cells: the role of self-renewal and differentiation.

Xiong-Zhi Wu1.   

Abstract

BACKGROUND: Self-renewal and differentiation potential is the feature of stem cells. Differentiation is usually considered to be a one-way process of specialization as cells develop the functions of their ultimate fate and lose their immature characteristics, such as self-renewal. Progenitor cells, the products of stem cells losing the activity of self-renewal, could differentiate to mature cells, which have the feature of differentiation and lose the activity of self-renewal. The roles for cancer stem cells have been demonstrated for some cancers. However, the origin of the cancer stem cells remains elusive.
METHODS: This review focuses on current scientific controversies related to the establishment of the cancer stem cells--in particular, how self-renewal and differentiation block might contribute to the evolution of cancer.
RESULTS: Cancer stem cells may be caused by transforming mutations occurring in multi-potential stem cells, tissue-specific stem cells, progenitor cells, mature cells and cancer cells. Progenitor cells obtain the self-renewal activity by activating the self-renewal-associated genes rather than dedifferentiate to tissue special stem cells. The transform multi-potential stem cells gain the differentiation feature of special tissue by differentiating to cancer cells. Mature cells and cancer cells may dedifferentiate or reprogram to cancer stem cells by genetic and / or epigenetic events to gain the self-renewal activity and lose some features of differentiation. The cancer-derived stem cells are not the "cause", but the "consequence" of carcinogenesis. The genetic program controlling self-renewal and differentiation is a key unresolved issue.
CONCLUSION: Cancer stem cells may be caused by disturbance of self-renewal and differentiation occurring in multi-potential stem cells, tissue-specific stem cells, progenitor cells, mature cells and cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18043974     DOI: 10.1245/s10434-007-9695-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  17 in total

1.  Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer.

Authors:  Pavol Zubor; Jozef Hatok; Petra Moricova; Karol Kajo; Ivana Kapustova; Andrea Mendelova; Peter Racay; Jan Danko
Journal:  Mol Biol Rep       Date:  2014-11-19       Impact factor: 2.316

2.  Carboxypeptidase A4 promotes proliferation and stem cell characteristics of hepatocellular carcinoma.

Authors:  Hongtao Zhang; Chengfei Hao; Haibo Wang; Haitao Shang; Zhonglian Li
Journal:  Int J Exp Pathol       Date:  2019-05-06       Impact factor: 1.925

3.  Potentiating effects of GHRH analogs on the response to chemotherapy.

Authors:  Andrew V Schally; Roberto Perez; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Regulation of stem cell populations by microRNAs.

Authors:  Julie Mathieu; Hannele Ruohola-Baker
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 5.  Signaling by discoidin domain receptor 1 in cancer metastasis.

Authors:  Mayur Gadiya; Goutam Chakraborty
Journal:  Cell Adh Migr       Date:  2018-10-13       Impact factor: 3.405

Review 6.  Using induced pluripotent stem cells as a tool for modelling carcinogenesis.

Authors:  Emma L Curry; Mohammad Moad; Craig N Robson; Rakesh Heer
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

7.  Safety of perioperative hyperthermic intraperitoneal chemotherapy with gemcitabine in patients with resected pancreatic adenocarcinoma: a pilot study of the clinical trial EudraCT 2016-004298-41.

Authors:  David Padilla-Valverde; Esther García-Santos; Susana Sanchez; Carmen Manzanares; Marta Rodriguez; Lucia González; Alfonso Ambrós; Juana M Cano; Leticia Serrano; Raquel Bodoque; Teresa Vergara; Jesus Martin
Journal:  J Gastrointest Oncol       Date:  2021-04

8.  Mesenchymal stem cell-derived hepatocytes for functional liver replacement.

Authors:  Bruno Christ; Peggy Stock
Journal:  Front Immunol       Date:  2012-06-22       Impact factor: 8.786

9.  Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.

Authors:  Rita Mancini; Enrico Giarnieri; Claudia De Vitis; Donatella Malanga; Giuseppe Roscilli; Alessia Noto; Emanuele Marra; Carmelo Laudanna; Pietro Zoppoli; Pasquale De Luca; Andrea Affuso; Luigi Ruco; Arianna Di Napoli; Giuseppe Mesiti; Luigi Aurisicchio; Alberto Ricci; Salvatore Mariotta; Lara Pisani; Claudio Andreetti; Giuseppe Viglietto; Erino A Rendina; Maria Rosaria Giovagnoli; Gennaro Ciliberto
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.

Authors:  Samuel L Collins; Rodolphe Hervé; C W Keevil; Jeremy P Blaydes; Jeremy S Webb
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.